Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Pacira Pharmaceuticals buy StockNews.com

Pacira Pharmaceuticals
Start price
€19.20
08.11.25 / 50%
Target price
-
08.11.26
Performance (%)
12.50%
Price
€21.60
30.12.25
Summary
This prediction is currently active. The BUY prediction by StockNews_com currently has a performance of 12.50%. This prediction currently runs until 08.11.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Pacira Pharmaceuticals 1.852% 1.852%
iShares Core DAX® 0.794% 2.841%
iShares Nasdaq 100 0.016% -0.939%
iShares Nikkei 225® 0.309% -0.648%
iShares S&P 500 0.181% -0.442%

Comments by StockNews_com for this prediction

In the thread Pacira Pharmaceuticals diskutieren

Pacira BioSciences (NASDAQ:PCRX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for PCRX provided by MarketBeat

StockNews.com 
0
Report Share
08.11.25 Buy 12.50%

Stopped prediction by StockNews_com for Pacira Pharmaceuticals

buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€35.80
05.08.23
-
05.08.24
-46.93%
06.08.24

StockNews.com 
05.08.23 50%